The terms of the settlement must be approved in court, and individual payouts may or may not be awarded. Each patient could receive about $350,000 in compensation.
The hip device made its global market debut in 2003 and was recalled in 2010 after sharply increasing failure rates from metallic debris being released as the device wears. Approximately 93,000 patients globally received the implant.
More Articles on Devices:
Device Companies — 7 Key Notes — Biomet, MAKO Surgical & More
Victrex Group Finance Director Steve Barrow to Step Down
Study Shows SpineJack Device Effective for Vertebral Compression Fracture Treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.